Letter to the Editor: In response to P.R. Clemens et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy

Detalles Bibliográficos
Autores principales: Muntoni, Francesco, Straub, Volker, Servais, Laurent, Mercuri, Eugenio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657664/
https://www.ncbi.nlm.nih.gov/pubmed/37955093
http://dx.doi.org/10.3233/JND-239004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657664/
https://www.ncbi.nlm.nih.gov/pubmed/37955093
http://dx.doi.org/10.3233/JND-239004

Ejemplares similares